These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 15285957)

  • 1. Physical health monitoring of patients with schizophrenia.
    Marder SR; Essock SM; Miller AL; Buchanan RW; Casey DE; Davis JM; Kane JM; Lieberman JA; Schooler NR; Covell N; Stroup S; Weissman EM; Wirshing DA; Hall CS; Pogach L; Pi-Sunyer X; Bigger JT; Friedman A; Kleinberg D; Yevich SJ; Davis B; Shon S
    Am J Psychiatry; 2004 Aug; 161(8):1334-49. PubMed ID: 15285957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health monitoring for patients who have schizophrenia. Summary of the Mount Sinai Conference recommendations.
    Covell NH; Jackson CT; Weissman EM
    Postgrad Med; 2006 Sep; Spec No():20-6. PubMed ID: 17128658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update.
    Moore TA; Buchanan RW; Buckley PF; Chiles JA; Conley RR; Crismon ML; Essock SM; Finnerty M; Marder SR; Miller DD; McEvoy JP; Robinson DG; Schooler NR; Shon SP; Stroup TS; Miller AL
    J Clin Psychiatry; 2007 Nov; 68(11):1751-62. PubMed ID: 18052569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From chlorpromazine to clozapine--antipsychotic adverse effects and the clinician's dilemma.
    Abidi S; Bhaskara SM
    Can J Psychiatry; 2003 Dec; 48(11):749-55. PubMed ID: 14733456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].
    Ames D; Camm J; Cook P; Falkai P; Gury C; Hurley R; Johnson G; Piepho R; Vieweg V;
    Encephale; 2002; 28(6 Pt 1):552-62. PubMed ID: 12506268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical issues associated with maintenance treatment of patients with schizophrenia.
    Guthrie SK
    Am J Health Syst Pharm; 2002 Sep; 59(17 Suppl 5):S19-24. PubMed ID: 12227083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic complications of schizophrenia and antipsychotic medications--an updated review.
    Yogaratnam J; Biswas N; Vadivel R; Jacob R
    East Asian Arch Psychiatry; 2013 Mar; 23(1):21-8. PubMed ID: 23535629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic and endocrine disturbances in psychiatric disorders: a multidisciplinary approach to appropriate atypical antipsychotic utilization.
    Masand PS; Culpepper L; Henderson D; Lee S; Littrell K; Newcomer JW; Rasgon N
    CNS Spectr; 2005 Oct; 10(10):suppl14 1-15. PubMed ID: 16404802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine-induced tardive dyskinesia in schizophrenic patients taking clozapine as a first-line antipsychotic drug.
    Li CR; Chung YC; Park TW; Yang JC; Kim KW; Lee KH; Hwang IK
    World J Biol Psychiatry; 2009; 10(4 Pt 3):919-24. PubMed ID: 19995222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting and Managing Adverse Effects of Antipsychotic Medications: Current State of Play.
    Ames D; Carr-Lopez SM; Gutierrez MA; Pierre JM; Rosen JA; Shakib S; Yudofsky LM
    Psychiatr Clin North Am; 2016 Jun; 39(2):275-311. PubMed ID: 27216904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach.
    Lund BC; Perry PJ; Brooks JM; Arndt S
    Arch Gen Psychiatry; 2001 Dec; 58(12):1172-6. PubMed ID: 11735847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motor and mental side effects of clozapine.
    Gerlach J; Peacock L
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():107-9. PubMed ID: 7961551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the new and evolving profile of adverse drug effects in schizophrenia.
    Wirshing DA; Pierre JM; Erhart SM; Boyd JA
    Psychiatr Clin North Am; 2003 Mar; 26(1):165-90. PubMed ID: 12683265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperglycemia and antipsychotic medications.
    Haupt DW; Newcomer JW
    J Clin Psychiatry; 2001; 62 Suppl 27():15-26; discussion 40-1. PubMed ID: 11806485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic issues in patients with severe mental illness.
    Citrome L; Blonde L; Damatarca C
    South Med J; 2005 Jul; 98(7):714-20. PubMed ID: 16108240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of monitoring and management guidelines for second-generation antipsychotics.
    Sernyak MJ
    J Clin Psychiatry; 2007; 68 Suppl 4():14-8. PubMed ID: 17539695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some adverse effects of antipsychotics: prevention and treatment.
    Lader M
    J Clin Psychiatry; 1999; 60 Suppl 12():18-21. PubMed ID: 10372605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic risk during antipsychotic treatment.
    Newcomer JW
    Clin Ther; 2004 Dec; 26(12):1936-46. PubMed ID: 15823759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.